Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.

about

Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.

Item

http://www.wikidata.org/entity/Q51770643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reduction of severe acute graf ...... related donor transplantation.

@en

Reduction of severe acute graf ...... related donor transplantation.

@nl

type

Item

label

Reduction of severe acute graf ...... related donor transplantation.

@en

Reduction of severe acute graf ...... related donor transplantation.

@nl

prefLabel

Reduction of severe acute graf ...... related donor transplantation.

@en

Reduction of severe acute graf ...... related donor transplantation.

@nl

P1476

Reduction of severe acute graf ...... related donor transplantation.

@en

P2093

Auro Viswabandya

http://www.w3.org/2001/XMLSchema#string

David Loach

http://www.w3.org/2001/XMLSchema#string

Dennis Dong-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Fotios V Michelis

http://www.w3.org/2001/XMLSchema#string

Hans A Messner

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Lipton

http://www.w3.org/2001/XMLSchema#string

Santhosh Thyagu

http://www.w3.org/2001/XMLSchema#string

Uday Deotare

http://www.w3.org/2001/XMLSchema#string

P2860

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis.

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre t

The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.

Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.

P2888

s41409-017-0053-9

P304

361-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41409-017-0053-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eshetu G. Atenafu

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29269806

http://www.w3.org/2001/XMLSchema#string